Gary L Rosner

5PUBLICATIONS
41CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methodsForensic evaluation, inference and statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 05, 2023
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response.

Shawn H R Lee, Wenjian Yang, Yoshihiro Gocho

|Aug 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

Diana Merino Vega, Katherine K Nishimura, Névine Zariffa

|May 03, 2021
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.

Jennifer J Griggs, Kari Bohlke, Edward P Balaban

|Feb 08, 2021
Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments.

Ian F Tannock, Mark J Ratain, Daniel A Goldstein

|Apr 07, 2020
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.

Gary L Rosner, Peter Müller

Pageof 1

Frequent Collaborators

1 joint publications

Peter Müller

1 joint publications

Ian F Tannock

1 joint publications

Mark J Ratain

1 joint publications

Daniel A Goldstein